Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report

Orphanet Journal of Rare Diseases

Volumn 10, Issue 1, 2015, Pages

  Boucher, Alexander A ^a   Miller, Weston ^b   Shanley, Ryan ^c   Ziegler, Richard ^a   Lund, Troy ^b   Raymond, Gerald ^a   Orchard, Paul J ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MMC 366   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Bone marrow transplantation; Hematopoietic stem cell transplantation; Metachromatic leukodystrophy; Umbilical cord blood transplantation

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CEREBROSIDE SULFATASE; CLOFARABINE; CYCLOPHOSPHAMIDE; LEUKOCYTE ANTIGEN; MELPHALAN; SULFATIDE;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORNELL BROWN SCALE; DAILY LIFE ACTIVITY; DEATH; DISABILITY SEVERITY; DISEASE COURSE; DONOR; ENZYME ACTIVITY; GROSS MOTOR FUNCTION CLASSIFICATION SYSTEM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; INTELLIGENCE QUOTIENT; LIFE EXPECTANCY; MEDICAL RECORD REVIEW; METACHROMATIC LEUKODYSTROPHY; MYELOABLATIVE CONDITIONING; NERVE CONDUCTION; NEUROPSYCHOLOGICAL TEST; NEUTROPHIL COUNT; NUCLEAR MAGNETIC RESONANCE IMAGING; QUALITY OF LIFE; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; SCORING SYSTEM; SIBLING; SURVIVAL RATE; UMBILICAL CORD BLOOD; VERBAL INTELLIGENCE QUOTIENT; VINELAND ADAPTIVE BEHAVIOR SCALE; WECHSLER FULL SCALE SCORE; WECHSLER INTELLIGENCE SCALE; WHOLE BODY RADIATION; ADOLESCENT; ADULT; ALLOTRANSPLANTATION; CHILD; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INFANT; LEUKODYSTROPHY, METACHROMATIC; MALE; PATHOLOGY; PRESCHOOL CHILD; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LEUKODYSTROPHY, METACHROMATIC; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84938796117     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/s13023-015-0313-y     Document Type: Article

References (44)

1. von Figura K, Gieselmann V, Jaeken J. Metachromatic Leukodystrophy. In: Scriver C, Beaudet A, Sly W, Valle D, editors. The Metabolic and Molecular Bases of Inherited Diseases, Eighth Edition, vol. 3. 8th ed. New York: McGraw-Hill; 2001.
2. Jeon S-B, Yoon H, Park S-H, Kim I-H, Park E. Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells. J Immunol. 2008;181:8077-87.
3. Gieselmann V. Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options. Acta Paediatr Suppl. 2008;97:15-21.
4. Shapiro EG, Lockman LA, Balthazor M, Krivit W. Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J Inherit Metab Dis. 1995;18:413-29.
5. MacFaul R, Cavanagh N, Lake BD, Stephens R, Whitfield AE. Metachromatic leucodystrophy: review of 38 cases. Arch Dis Child. 1982;57:168-75.
6. Shapiro EG, Lockman LA, Knopman D, Krivit W. Characteristics of the dementia in late-onset metachromatic leukodystrophy. Neurology. 1994;44:662-5.
7. Martin H, Poe M, Provenzale J, Kurtzberg J, Mendizabal A, Escolar M. Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy. Biol Blood Marrow Transplant. 2013;19:616-24.
8. Solders M, Martin DA, Andersson C, Remberger M, Andersson T, Ringdén O, et al. Hematopoietic SCT: a useful treatment for late metachromatic leukodystrophy. Bone Marrow Transplant. 2014;49:1046-51.
9. Kapaun P, Dittmann RW, Granitzny B, Eickhoff W, Wulbrand H, Neumaier Probst E, et al. Slow progression of juvenile metachromatic leukodystrophy 6 years after bone marrow transplantation. J Child Neurol. 1999;14:222-8.
10. Görg M, Wilck W, Granitzny B, Suerken A, Lukacs Z, Ding X, et al. Stabilization of juvenile metachromatic leukodystrophy after bone marrow transplantation: a 13-year follow-up. J Child Neurol. 2007;22:1139-42.
11. Kidd D, Nelson J, Jones F, Dusoir H, Wallace I, McKinstry S, et al. Long-term stabilization after bone marrow transplantation in juvenile metachromatic leukodystrophy. Arch Neurol. 1998;55:98-9.
12. Cable C, Finkel R, Lehky T, Biassou N, Wiggs E, Bunin N, et al. Unrelated umbilical cord blood transplant for juvenile metachromatic leukodystrophy: a 5-year follow-up in three affected siblings. Mol Genet Metab. 2011;102:207-9.
13. Solders G, Celsing G, Hagenfeldt L, Ljungman P, Isberg B, Ringdén O. Improved peripheral nerve conduction, EEG and verbal IQ after bone marrow transplantation for adult metachromatic leukodystrophy. Bone Marrow Transplant. 1998;22:1119-22.
14. de Hosson LD, van de Warrenburg BPC, Preijers FWMB, Blijlevens NMA, van der Reijden BA, Kremer HPH, et al. Adult metachromatic leukodystrophy treated by allo-SCT and a review of the literature. Bone Marrow Transplant. 2011;46:1071-6.
15. Krivit W, Peters C, Shapiro EG. Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr Opin Neurol. 1999;12:167-76.
16. Bredius RGM, Laan LAEM, Lankester AC, Poorthuis BJHM, van Tol MJD, Egeler RM, et al. Early marrow transplantation in a pre-symptomatic neonate with late infantile metachromatic leukodystrophy does not halt disease progression. Bone Marrow Transplant. 2007;39:309-10.
17. Artigalás O, Lagranha VL, Saraiva-Pereira ML, Burin MG, Lourenço CM, van der Linden H, et al. Clinical and biochemical study of 29 Brazilian patients with metachromatic leukodystrophy. J Inherit Metab Dis. 2010;33 Suppl 3:S257-62.
18. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus conference on acute GVHD Grading. Bone Marrow Transplant. 1995;15:825-8.
19. Filipovich A, Weisdorf D, Pavletic S, Socie G, Wingard J, Lee S, et al. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945-56.
20. Kehrer C, Blumenstock G, Gieselmann V, Krägeloh-Mann I, Leukonet G. The natural course of gross motor deterioration in metachromatic leukodystrophy. Dev Med Child Neurol. 2011;53:850-5.
21. Kehrer C, Blumenstock G, Raabe C, Krägeloh Mann I. Development and reliability of a classification system for gross motor function in children with metachromatic leucodystrophy. Dev Med Child Neurol. 2011;53:156-60.
22. Kehrer C, Groeschel S, Kustermann-Kuhn B, Bürger F, Köhler W, Kohlschütter A, et al. Language and cognition in children with metachromatic leukodystrophy: onset and natural course in a nationwide cohort. Orphanet J Rare Dis. 2014;9:18.
23. Wechsler D. Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV). San Antonio, TX: Psychological Corporation; 2003.
24. Roid G. Stanford-Binet Intelligence Scales. 5th ed. Rolling Meadows, IL: Riverside Publishing; 2003.
25. Bayley. Bayley Scales of Infant and Toddler Development. 2006.
26. Sparrow. Vineland Adaptive Behavior Scales, "Survey Form Manual", Second Edition. 2005.
27. Ready RE, Ott BR, Grace J, Fernandez I. The Cornell-Brown scale for quality of life in dementia. Alzheimer Dis Assoc Disord. 2002;16:109-15.
28. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-81.
29. Lin DY. Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med. 1997;16:901-10.
30. Rafi MA, Coppola S, Liu SL, Rao HZ, Wenger DA. Disease-causing mutations in cis with the common arylsulfatase A pseudodeficiency allele compound the difficulties in accurately identifying patients and carriers of metachromatic leukodystrophy. Mol Genet Metab. 2003;79:83-90.
31. Wilkinson FL, Sergijenko A, Langford-Smith KJ, Malinowska M, Wynn RF, Bigger BW. Busulfan conditioning enhances engraftment of hematopoietic donor-derived cells in the brain compared with irradiation. Mol Ther. 2013;21:868-76.
32. Capotondo A, Milazzo R, Politi LS, Quattrini A, Palini A, Plati T, et al. Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation. Proc Natl Acad Sci U S A. 2012;109:15018-23.
33. Mahmood A, Berry J, Wenger DA, Escolar M, Sobeih M, Raymond G, et al. Metachromatic leukodystrophy: a case of triplets with the late infantile variant and a systematic review of the literature. J Child Neurol. 2010;25:572-80.
34. Biffi A, Cesani M, Fumagalli F, Del Carro U, Baldoli C, Canale S, et al. Metachromatic leukodystrophy - mutation analysis provides further evidence of genotype-phenotype correlation. Clin Genet. 2008;74:349-57.
35. van Egmond M, Pouwels PJW, Boelens J-J, Lindemans C, Barkhof F, Steenwijk M, et al. Improvement of white matter changes on neuroimaging modalities after stem cell transplant in metachromatic leukodystrophy. JAMA Neurol. 2013;70:779-82.
36. Groeschel S, í Dali C, Clas P, Böhringer J, Duno M, Krarup C, et al. Cerebral gray and white matter changes and clinical course in metachromatic leukodystrophy. Neurology. 2012;79:1662-70.
37. Peters C, Steward CG, Program NMD, Registry IBMT, Working Party on Inborn Errors ErBMTG. Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines. Bone Marrow Transplant. 2003;31:229-39.
38. Koç ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 2002;30:215-22.
39. Krägeloh Mann I, Groeschel S, Kehrer C, Opherk K, Nägele T, Handgretinger R, et al. Juvenile metachromatic leukodystrophy 10 years post transplant compared with a non-transplanted cohort. Bone Marrow Transplant. 2013;48:369-75.
40. Pridjian G, Humbert J, Willis J, Shapira E. Presymptomatic late-infantile metachromatic leukodystrophy treated with bone marrow transplantation. J Pediatr. 1994;125:755-8.
41. Biffi A, Montini E, Lorioli L, Cesani M, Fumagalli F, Plati T, et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science. 2013;341:1233158.
42. Barcenas M, Suhr TR, Scott CR, Turecek F, Gelb MH. Quantification of sulfatides in dried blood and urine spots from metachromatic leukodystrophy patients by liquid chromatography/electrospray tandem mass spectrometry. Clin Chim Acta. 2014;433:39-43.
43. Batzios S, Zafeiriou D. Developing treatment options for metachromatic leukodystrophy. Mol Genet Metab. 2012;105:56-63.
44. Patil S, Maegawa GHB. Developing therapeutic approaches for metachromatic leukodystrophy. Drug Des Devel Ther. 2013;7:729-45.